Targeting Hsp70: A possible therapy for cancer

Area of Science:

• Molecular Biology
• Cellular Stress Response
• Cancer Therapeutics

Background:

• Heat-shock proteins (HSPs) are ancient molecular chaperones crucial for protein homeostasis and cellular defense.
• Hsp70, a key member of the HSP family, interacts with diverse proteins, offering cytoprotection against various stresses.
• Elevated Hsp70 expression is implicated in cancer cell survival, tumorigenesis, and resistance to chemotherapy.

Purpose of the Study:

• To review the multifaceted roles of Hsp70 in cancer development and progression.
• To explore therapeutic strategies targeting Hsp70 for cancer treatment.

Main Methods:

• Review of existing literature on Hsp70 function in cellular stress and cancer.
• Analysis of Hsp70's involvement in protein folding, apoptosis, and immune response.
• Examination of preclinical and clinical data on Hsp70-targeted cancer therapies.

Main Results:

• Hsp70 promotes cancer cell survival and chemoresistance by inhibiting apoptosis.
• Extracellular Hsp70 functions as an immunogen, influencing anti-tumor immunity.
• Inhibition or knockdown of Hsp70 has demonstrated tumor size reduction and regression in preclinical models.

Conclusions:

• Hsp70 plays a critical dual role in cancer, promoting survival and potentially aiding anti-tumor immunity.
• Targeting Hsp70 represents a promising therapeutic strategy for various cancers.
• Further research into Hsp70-directed therapies could lead to novel cancer treatment approaches.